Toll Free: 1-888-928-9744

Global Topiramate (CAS 97240-79-4) Market Outlook 2016-2021

Published: Sep, 2016 | Pages: 100 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Topiramate (brand name Topamax) is an anticonvulsant (antiepilepsy) drug. In late 2012, topiramate was approved by the United States Food and Drug Administration (FDA) in combination with phentermine for weight loss. The drug had previously been used off-label for this purpose. Topiramate was originally produced by Ortho-McNeil Neurologics and Noramco, Inc., both divisions of the Johnson & Johnson Corporation. This medication was discovered in 1979 by Bruce E. Maryanoff and Joseph F. Gardocki during their research work at McNeil Pharmaceutical.

This report provides detailed analysis of worldwide markets for Topiramate (CAS 97240-79-4) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Topiramate (CAS 97240-79-4) market and further lays out an analysis of the factors influencing the supply/demand for Topiramate (CAS 97240-79-4), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Topiramate (CAS 97240-79-4) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Topiramate (CAS 97240-79-4) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Topiramate (CAS 97240-79-4) market are Unimark Remedies (India), Janssen Pharmaceutica (Belgium), Taj Pharmaceuticals (India), ScinoPharm (Taiwan), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Topiramate (CAS 97240-79-4) industry has been provided.
 Table of Contents
Part 1. Scope of Report 1.1 Methodology 1.2 Geographic Scope 1.3 Years Considered Part 2. Introduction 2.1 Definition 2.2 Current Scenario 2.2 Future Scenario Part.3 Value Chain Analysis 3.1 Upstream 3.2 Downstream Part 4. Manufacture 4.1 Manufacturing Process 4.2 Issues and Trends 4.3 Manufacturing Costs Part 5. Worldwide Key Vendors 5.1 Company A 5.1.1 Business Overview 5.1.2 Products Offered 5.1.3 Business Performance 5.2 Company B 5.3 Company C 5.4 Company D 5.5 Company E 5.6 Company F 5.7 Company G 5.8 Company H 5.9 Company I 5.10 Company J Part 6. Market Overview 6.1 Global Production Volume 2011-2016 6.2 Production Volume by Region 2011-2016 6.2.1 North America 6.2.2 EMEA 6.2.3 Asia-Pacific 6.2.4 ROW 6.3 Global Production Value 2011-2016 6.4 Production Value by Region 6.4.1 North America 6.4.2 EMEA 6.4.3 Asia-Pacific 6.4.4 ROW Part 7. Consumption Pattern 7.1 Regional Consumption 7.1.1 North America 7.1.2 EMEA 7.1.3 Asia-Pacific 7.1.4 ROW 7.2 Global Consumption by Application Part 8. Market Forecast 8.1 Market Size by Volume 8.1.1 North America 8.1.2 EMEA 8.1.3 Asia-Pacific 8.1.4 ROW 8.2 Market Size by Value 8.2.1 North America 8.2.2 EMEA 8.2.3 Asia-Pacific 8.2.4 ROW 8.3 Regional Consumption Forecast 8.3.1 North America 8.3.2 EMEA 8.3.3 Asia-Pacific 8.3.4 ROW 8.4 Consumption Forecast by Application Part 9. Market Dynamics 9.1 Market Drivers 9.2 Market Constraints 9.3 Market Strategies Part 10. Key Events 10.1 Mergers & Acquisitions 10.2 New Product Launches 10.3 Expansions 10.4 Other Developments List of Tables and Figures
Figure Global Topiramate (CAS 97240-79-4) Production Volume (Unit) 2011-2016 Figure Global Topiramate (CAS 97240-79-4) Production Value (M USD) 2011-2016 Figure Top 10 Topiramate (CAS 97240-79-4) Vendors Production Volume Share 2015 Figure Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value Share 2015 Figure Regional Topiramate (CAS 97240-79-4) Production (Unit) 2015 Figure Regional Topiramate (CAS 97240-79-4) Production Value (M USD) 2015 Table Raw Material Materials Suppliers Figure Global Topiramate (CAS 97240-79-4) Consumption Pattern 2015 Figure Manufacturing Cost Structure Figure Company A Topiramate (CAS 97240-79-4) Products Table Company A Financial Performance 2011-2016 Figure Company A Market Share 2011-2016 Figure Company B Topiramate (CAS 97240-79-4) Products Table Company B Financial Performance 2011-2016 Figure Company B Market Share 2011-2016 Figure Company C Topiramate (CAS 97240-79-4) Products Table Company C Financial Performance 2011-2016 Figure Company C Market Share 2011-2016 Figure Company D Topiramate (CAS 97240-79-4) Products Table Company D Financial Performance 2011-2016 Figure Company D Market Share 2011-2016 Figure Company E Topiramate (CAS 97240-79-4) Products Table Company E Financial Performance 2011-2016 Figure Company E Market Share 2011-2016 Figure Company F Topiramate (CAS 97240-79-4) Products Table Company F Financial Performance 2011-2016 Figure Company F Market Share 2011-2016 Figure Company G Topiramate (CAS 97240-79-4) Products Table Company G Financial Performance 2011-2016 Figure Company G Market Share 2011-2016 Figure Company H Topiramate (CAS 97240-79-4) Products Table Company H Financial Performance 2011-2016 Figure Company H Market Share 2011-2016 Figure Company I Topiramate (CAS 97240-79-4) Products Table Company I Financial Performance 2011-2016 Figure Company I Market Share 2011-2016 Figure Company J Topiramate (CAS 97240-79-4) Products Table Company J Financial Performance 2011-2016 Figure Company J Market Share 2011-2016 Table Global Key Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2011-2016 Table Global Key Topiramate (CAS 97240-79-4) Vendors Production Share 2011-2016 Figure Global Topiramate (CAS 97240-79-4) Capacity & Production (Unit), Capacity Utilization 2011-2016 Figure Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2011-2016 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2011 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2012 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2013 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2014 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2015 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production (Unit) 2016 Figure Topiramate (CAS 97240-79-4) Production Volume (Unit) 2011-2016 Table Global Production Volume (Unit) 2011-2016 Table Global Production Volume Share 2011-2016 Figure North America Topiramate (CAS 97240-79-4) Capacity & Production (Unit) Figure North America Production Share Trend Figure EMEA Topiramate (CAS 97240-79-4) Capacity & Production (Unit) Figure EMEA Production Share Trend Figure Asia-Pacific Topiramate (CAS 97240-79-4) Capacity & Production (Unit) Figure Asia-Pacific Production Share Trend Figure ROW Topiramate (CAS 97240-79-4) Capacity & Production (Unit) Figure ROW Production Share Trend Change Figure Global Topiramate (CAS 97240-79-4) Production Value (M USD), Growth Rate Table Global Key Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2011-2016 Table Global Key Topiramate (CAS 97240-79-4) Vendors Production Value Share 2011-2016 Figure Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2011-2016 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2011 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2012 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2013 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2014 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2015 Table Global Top 10 Topiramate (CAS 97240-79-4) Vendors Production Value (M USD) 2016 Figure Topiramate (CAS 97240-79-4) Prices (USD/Ton) 2016 Figure Topiramate (CAS 97240-79-4) Gross Margin 2016 Figure Topiramate (CAS 97240-79-4) Production Value (M USD) By Region 2011-2016 Table Global Topiramate (CAS 97240-79-4) Production Value (M USD) 2011-2016 Table Global Topiramate (CAS 97240-79-4) Production Value Share 2011-2016 Figure North America Production Value (M USD), Growth Rate Figure North America Topiramate (CAS 97240-79-4) Production Value Share Trend Figure EMEA Production Value (M USD), Growth Rate Figure EMEA Topiramate (CAS 97240-79-4) Production Value Share Trend Figure Asia-Pacific Production Value (M USD), Growth Rate Figure Asia-Pacific Topiramate (CAS 97240-79-4) Production Value Share Trend Figure ROW Production Value (M USD), Growth Rate Figure ROW Topiramate (CAS 97240-79-4) Production Value Share Trend Figure Global Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2015 Table Regional Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2011-2016 Table Regional Topiramate (CAS 97240-79-4) Consumption Volume Share 2011-2016 Figure Topiramate (CAS 97240-79-4) Consumption in North America 2011-2016 Figure Topiramate (CAS 97240-79-4) Consumption in EMEA 2011-2016 Figure Topiramate (CAS 97240-79-4) Consumption in Asia-Pacific 2011-2016 Figure Topiramate (CAS 97240-79-4) Consumption in ROW 2011-2016 Figure Global Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2016 Table Global Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2011-2016 Table Global Topiramate (CAS 97240-79-4) Consumption Volume Share 2011-2016 Figure Global Topiramate (CAS 97240-79-4) Production (Unit) Forecast 2016-2021 Table Global Topiramate (CAS 97240-79-4) Production (Unit) 2016-2021 Table Global Topiramate (CAS 97240-79-4) Production Share 2016-2021 Figure North Topiramate (CAS 97240-79-4) Production (Unit) Forecast 2016-2021 Figure EMEA Topiramate (CAS 97240-79-4) Production (Unit) Forecast 2016-2021 Figure Asia-Pacific Topiramate (CAS 97240-79-4) Production (Unit) Forecast 2016-2021 Figure ROW Topiramate (CAS 97240-79-4) Production (Unit) Forecast 2016-2021 Figure Global Topiramate (CAS 97240-79-4) Revenue (M USD) Forecast 2016-2021 Table Global Topiramate (CAS 97240-79-4) Revenue (M USD) 2016-2021 Table Global Topiramate (CAS 97240-79-4) Revenue Share 2016-2021 Figure North America Topiramate (CAS 97240-79-4) Revenue (M USD) Forecast 2016-2021 Figure EMEA Topiramate (CAS 97240-79-4) Revenue (M USD) Forecast 2016-2021 Figure Asia-Pacific Topiramate (CAS 97240-79-4) Revenue (M USD) Forecast 2016-2021 Figure ROW Topiramate (CAS 97240-79-4) Revenue (M USD) Forecast 2016-2021 Figure Global Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2016-2021 Table Global Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2016-2021 Table Global Topiramate (CAS 97240-79-4) Consumption Volume Share 2016-2021 Figure North America Topiramate (CAS 97240-79-4) Consumption (Unit) Forecast Figure EMEA Topiramate (CAS 97240-79-4) Consumption (Unit) Forecast Figure Asia-Pacific Topiramate (CAS 97240-79-4) Consumption (Unit) Forecast Figure ROW Topiramate (CAS 97240-79-4) Consumption (Unit) Forecast Figure Global Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2021 Table Global Topiramate (CAS 97240-79-4) Consumption Volume (Unit) 2016-2021 Table Global Topiramate (CAS 97240-79-4) Consumption Volume Share 2016-2021 Table Key Strategies for Topiramate (CAS 97240-79-4) Multinational Corporations Table Key Strategies for Topiramate (CAS 97240-79-4) Emerging-Market Players

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $2800
Multi User - US $5600
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify